Protein synthesis and urokinase mRNA metabolism

Molecular and Cellular Biochemistry

Volumn 271, Issue 1-2, 2005, Pages 13-22

  Shetty, Sreerama ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Inflammation; mRNA; Neoplasia translation inhibition; Protein synthesis; Urokinase

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ANISOMYCIN; CYCLOHEXIMIDE; EMETINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HUR PROTEIN; MESSENGER RNA; PUROMYCIN; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; DOWN REGULATION; ENZYME METABOLISM; ENZYME STABILITY; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR INTERACTION; NORTHERN BLOTTING; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RNA TRANSCRIPTION; RNA TRANSLATION; RNA TRANSPORT; TRANSCRIPTION REGULATION;

ANTIGENS, SURFACE; BRONCHI; CELLS, CULTURED; CYCLOHEXIMIDE; EPITHELIAL CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HUMANS; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 17244363646     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-3453-x     Document Type: Article

References (40)

1. Gyetko MR, Todd III RF, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 93: 1380-1387, 1994
2. Gyetko MR, Sitrin RG, Fuller JA, Todd III RF, Petty H, Standiford TJ: Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leuk Biol 58: 533-538, 1995
3. Dumler I, Weis A, Mayboroda OA et al. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem 273(1): 315-321, 1998
4. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR: Urokinase receptor is associated with the components of JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272(45): 28563-28567, 1997
5. Chapman H: Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9: 714-724, 1997
6. Shetty S, Idell S: Posttranscriptional regulation of urokinase mRNA: Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J Biol Chem 275: 13771-13779, 2000
7. Altus MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. J Biol Chem 266: 21190-21196, 1991
8. Akashi M, Shaw G, Gross M, Saito, M, Koeffler HP: Role of AUUU sequences in stabilization of granulocyte-macrophage colony-stimulating factor RNA in stimulated cells. Blood 78: 2005-2012, 1991
9. Caput D, Beutler B, Hortog K, Thayer R, Brown-Shimer, S, Cerami: A Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83: 1670-1674, 1986 1:CAS:528:DyaL28XktF2lsbw%3D
10. Shaw G, Kamen RA: Conserved AU sequence from the 3′untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986 10.1016/0092-8674(86)90341-7
11. Jones TR, Cole MD: Rapid cytoplasmic turnover of c-myc mRNA; requirement of the 3′untanslated sequences. Mol Cell Biol 7: 4513-4521, 1987
12. Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR: Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci USA 95, 6296-6301, 1998
13. Nanbu R, Menoud P-A, Nagamine Y: Multiple instability-regulating sites in the 3′untranslated region of the urokinase-type plasminogen activator mRNA. Mol Cell Biol 14: 4920-4928, 1994
14. Heaton JH, Tillman-Bogush M, Leff NS, Gelehrter TD: Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. J Biol Chem 273, 14261-14268, 1998
15. Tillman-Bogush M, Heaton JH, Gelehrter TD: Cyclic nucleotide regulation of PAI-1 mRNA stability: Identification of cytosolic proteins that interact with an A-Rich sequence. J Biol Chem 274: 1172-1179, 1999
16. Maurer F, Tiernay M, Medcalf RL: An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucl Acid Res 27: 1664-1673, 1999
17. Wilson T, Triesman R: Removal of poly (A) and consequent degradation of c-fos mRNA facilitated by 3′AU-rich sequences. Nature 336: 396-399, 1988
18. Casey JL, Koeller DM, Ramin VC, Klausner RD, Harford JB: Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J 12: 3693-3699, 1989
19. Mullner EW, Kuhn LC: A stem-loop in the 3′untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53: 815-825, 1988
20. Levine BJ, Chodchoy N, Marzluff WF, Skoultchi AI: Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc Natl Acad Sci 84: 6189-6193, 1987
21. Iwai Y, Akahane K, Cohen, RB: Ca ionophore A23187-dependent stabilization of granulocyte-macrophage colony-stimulating factor messenger RNA in murine thymoma EL-4 cells is mediated through two distinct regions in the 3′-untranslated region. J Immunol 150: 4386-4394, 1993
22. Parkar R, Jacobson A: Translation and a 42-nucleotide segment within the coding region of the mRNA encoded by the MATα1 gene are involved in promoting rapid mRNA decay in yeast. Proc Natl Acad Sci USA 87: 2780-2784, 1990
23. Shetty S, Kumar A, Idell S: Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 17: 1075-1083, 1997
24. Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P: Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a posttranscriptional mechanism. FEBS Lett 508: 379-384, 2001
25. Tiernay M, Medcalf RL: Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. J Biol Chem 276: 13675-13684, 2001
26. Davis CA, Monnier JM, Nick HS: A coding region determinant of instability regulates levels of manganese superoxide dismutase mRNA. J Biol Chem 276: 37317-37326, 2001
27. Altus, MS, Nagamine Y: Protein synthesis inhibition stabilizes urokinase-type plasminogen activator mRNA. Studies in vivo and in cell-free decay reactions. J Biol Chem 266: 21190-21196, 1991
28. Ziegler A, Knesel J, Fabbro D, Nagamine Y: Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem 266: 21067-21074, 1991
29. Henderson BR, McDonald DA, Kefford RF: Posttranscriptional regulation of urokinase plasminogen activator gene expression occurs in the nucleus of BC1 rat mammary tumor cells. Int J Cancer 50: 918-923, 1992
30. Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF: Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in mestatic tumor cells. Cancer Res 52: 2489-2496, 1992
31. Shetty S, Idell S: Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 276: 24549-24556, 2001
32. Shetty S, Bdeir K Cines D, Idell S: Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 278: 18124-18131, 2003
33. Antalis TM, Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucl Acid Res 19: 4301, 1991
34. Shetty S: Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability. Mol Cell Biochem 237: 55-67, 2002 10.1023/A:1016558200199
35. Tran H, Maurer F, Nagamine Y: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated kinase 2. Mol Cell Biol 23: 7177-7188, 2003
36. Nanbu R, Montero, L., D'Orazio D, Nagamine Y: Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1, cells down-regulated for protein kinase C. Eur J Biochem 247: 169-174, 1997
37. Marshall BC, Xu Q-P, Rao NV, Brown BR, Hoidal JR: Pulmonary epithelial Cell urokinase-type plasminogen activator. J Biol Chem 267: 11462-11469, 1990
38. Saksel O: Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 823: 35-65, 1985
39. Blasi F, Vassali JD, Dano K: Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors. J Biol Chem 104: 801-804, 1987
40. Wang Z, Kiledjian M: Identification of erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage EMBO J 19: 295-305, 2000